A Phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage Radiotherapy following a Radical Prostatectomy: Results of the TROG 08.03 and ANZUP “RAVES” Trial

Adjuvant radiotherapy (ART) has been shown to nearly halve the risk of biochemical failure (BF) for high risk post prostatectomy patients. The RAVES trial aimed to test the hypothesis that observation with early salvage radiotherapy (SRT) is not inferior to ART with respect to biochemical failure in patients with high risk disease after radical prostatectomy (RP). Eligible patients needed to have either extraprostatic extension, seminal vesicle...